Cadila News: Read Latest News & Live Updates on Cadila, Photos, Videos at CNBCTV18.com

homeCadila News

Cadila NEWS

All

healthcare | Aug 27, 2021 9:07 AM IST
Gland Pharma increases contract manufacturing of Remdesivir, now doing it for four companies
market | Jul 6, 2021 2:08 PM IST
Indian pharma market grows 14% in June 2021; analysts see normalisation
healthcare | May 28, 2021 4:07 PM IST
Boosting vaccine production: Here's where Cadila, Strides Pharma stand
earnings | May 26, 2021 7:01 PM IST
Cadila Healthcare Q4FY21 earnings preview: Revenue expected to grow by 3%
business | Apr 9, 2021 1:50 PM IST
Remdesivir shortage: Cipla, Cadila ramping-up production
market | Aug 25, 2020 1:30 PM IST
Q1FY21 Review: Pharma cos posted stellar results but industry not out of the woods, says JM Financial
market | Feb 17, 2020 8:40 AM IST
CNBC-TV18's buzzing stocks for trade on February 17
photos | Feb 17, 2020 8:01 AM IST
CNBC-TV18's top stocks to watch out for on February 17
healthcare | Jan 20, 2020 2:47 PM IST
USFDA increases inspections of Indian drug facilities, investors remain concerned
market | Dec 23, 2019 8:35 AM IST
CNBC-TV18's buzzing stocks for trade on December 23
photos | Dec 23, 2019 7:49 AM IST
CNBC-TV18's top stocks to watch out for on December 23
healthcare | Sept 3, 2019 7:47 PM IST
Government asks pharma majors to manufacture drugs in India to boost "Make in India" campaign
photos | Aug 5, 2019 4:55 PM IST
This is how pharma industry CEOs' pay was impacted by last fiscal’s slowdown
healthcare | Jul 12, 2019 11:43 AM IST
HDFC Securities positive on domestic midcap pharma stocks
healthcare | Feb 27, 2019 11:56 AM IST
Planning to launch over 40 products this year, says Cadila

Cadila NEWS

Gland Pharma increases contract manufacturing of Remdesivir, now doing it for four companies

Indian pharma market grows 14% in June 2021; analysts see normalisation

Boosting vaccine production: Here's where Cadila, Strides Pharma stand

Cadila Healthcare Q4FY21 earnings preview: Revenue expected to grow by 3%

Remdesivir shortage: Cipla, Cadila ramping-up production

Q1FY21 Review: Pharma cos posted stellar results but industry not out of the woods, says JM Financial

CNBC-TV18's buzzing stocks for trade on February 17

CNBC-TV18's top stocks to watch out for on February 17

​USFDA increases inspections of Indian drug facilities, investors remain concerned

CNBC-TV18's buzzing stocks for trade on December 23

CNBC-TV18's top stocks to watch out for on December 23

Government asks pharma majors to manufacture drugs in India to boost "Make in India" campaign

This is how pharma industry CEOs' pay was impacted by last fiscal’s slowdown

HDFC Securities positive on domestic midcap pharma stocks

Planning to launch over 40 products this year, says Cadila

USFDA increases inspections of Indian drug facilities, investors remain concerned